Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 2Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Multiple Myeloma 40Neoplasms, Plasma Cell 13Lymphoma 12Neuroblastoma 10Leukemia, Myeloid, Acute 10Lymphoma, Large B-Cell, Diffuse 9Immunoglobulin Light-chain Amyloidosis 8Lymphoma, Non-Hodgkin 6Myelodysplastic Syndromes 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Follicular 5Uveal Melanoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms 3Melanoma 3Lymphoma, Mantle-Cell 3Leukemia 3Amyloidosis 3Neoplasm Metastasis 2Hodgkin Disease 2Ganglioneuroblastoma 2Venentoclax 1Smoldering Multiple Myeloma 1Sarcoma, Ewing 1Sarcoma 1Retinoblastoma 1Rectal Neoplasms 1Ovarian Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms by Histologic Type 1

Interventions

Paclitaxel 30Carboplatin 24Cisplatin 11Topotecan 8liposomal doxorubicin 6Hyperthermic Intraperitoneal Chemotherapy 6mirvetuximab soravtansine 5Cyclophosphamide 5Drug Therapy 4Chemotherapy, Adjuvant 4Bevacizumab 4rucaparib 3Peripheral Blood Stem Cell Transplantation 3Neoadjuvant Therapy 3Doxorubicin 3Docetaxel 3CP protocol 3olaparib 2liposomal amphotericin B 2Surgical Procedures, Operative 2Letrozole 2Gemcitabine 2trebananib 1trastuzumab deruxtecan 1phenoxodiol 1pembrolizumab 1oregovomab 1niraparib 1fluzoparib 1epothilone B 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Carcinoma, Ovarian Epithelial × Melphalan × Clear all
NCT00004921 2013-09-17

High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery

National Cancer Institute (NCI)

Phase 3 Completed
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡